Source:http://linkedlifedata.com/resource/pubmed/id/15306175
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-8-12
|
pubmed:abstractText |
We have previously shown that intravenous apolipoprotein (apo) A-I/phosphatidylcholine (apo A-I/PC) discs increase plasma high-density lipoprotein (HDL) concentration in humans. We have now studied the associated changes in two enzymes, paraoxonase (PON) and platelet-activating factor acetylhydrolase (PAF-AH) that are carried in whole or in part by HDLs, and are thought to influence atherogenesis by hydrolyzing oxidized phospholipids in lipoproteins. Apo A-I/PC discs (40 mg/kg over 4 h) were infused into eight healthy males. Although plasma apo A-I and HDL cholesterol increased on average by 178 and 158%, respectively, plasma total PON and total PAF-AH concentrations did not rise. By the end of the infusion, HDL-associated PAF-AH had increased by 0.56 +/- 0.14 microg/mL (mean +/- S.D., P < 0.01), and nonHDL-associated PAF-AH had decreased by 0.84 +/- 0.11 microg/mL (P < 0.05). These changes were accompanied by an increase in the HDL-associated PAF-AH/apo A-I ratio from 0.19 to 0.35 (P < 0.05), and by a decrease in the nonHDL-associated PAF-AH/apo B ratio from 2.1 to 1.4 (P < 0.05). No changes in PON or PAF-AH concentrations were detected in prenodal lymph (tissue fluid), collected continuously from the leg. Our results show that the total concentrations of PON and PAF-AH in plasma are uninfluenced by plasma HDL concentration. PAF-AH transfers readily between HDLs and LDLs in vivo, and its distribution between them is determined partly by their relative concentrations and partly by HDL composition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Alkyl-2-acetylglycerophosphocholin...,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Aryldialkylphosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylcholines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-9150
|
pubmed:author |
pubmed-author:CookeC JustinCJ,
pubmed-author:EgashiraTohruT,
pubmed-author:HattoriHiroakiH,
pubmed-author:IshiharaMitsuakiM,
pubmed-author:ItoMayumiM,
pubmed-author:IwasakiTadaoT,
pubmed-author:KujiraokaTakeshiT,
pubmed-author:MillerNorman ENE,
pubmed-author:NaganoMakotoM,
pubmed-author:NanjeeM NazeemMN,
pubmed-author:OlszewskiWaldemar LWL,
pubmed-author:StepanovaIrina PIP
|
pubmed:issnType |
Print
|
pubmed:volume |
176
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-62
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15306175-1-Alkyl-2-acetylglycerophosphocholine Esterase,
pubmed-meshheading:15306175-Adult,
pubmed-meshheading:15306175-Apolipoprotein A-I,
pubmed-meshheading:15306175-Arteriosclerosis,
pubmed-meshheading:15306175-Aryldialkylphosphatase,
pubmed-meshheading:15306175-Cholesterol, HDL,
pubmed-meshheading:15306175-Cholesterol, LDL,
pubmed-meshheading:15306175-Enzyme Activation,
pubmed-meshheading:15306175-Humans,
pubmed-meshheading:15306175-Injections, Intravenous,
pubmed-meshheading:15306175-Lymph,
pubmed-meshheading:15306175-Male,
pubmed-meshheading:15306175-Phosphatidylcholines
|
pubmed:year |
2004
|
pubmed:articleTitle |
Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
|
pubmed:affiliation |
Department of Advanced Medical Technology and Development, BML Inc, 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|